BUSOL 0.004 MG/ML SOLUTION FOR INJECTION FOR CATTLE, HORSES, RABBITS

Land: Ierland

Taal: Engels

Bron: HPRA (Health Products Regulatory Authority)

Koop het nu

Download Productkenmerken (SPC)
05-04-2017

Werkstoffen:

BUSERELIN (AS BUSERELIN ACETATE PH. EUR.)

Beschikbaar vanaf:

T.P. Whelehan Son & Co. Ltd.,

ATC-code:

QH01CA90

INN (Algemene Internationale Benaming):

BUSERELIN (AS BUSERELIN ACETATE PH. EUR.)

Dosering:

0.004 Mg/Ml

farmaceutische vorm:

Solution for Injection

Prescription-type:

POM

Therapeutische categorie:

Bovine, Equine - Food, Rabbits

Therapeutisch gebied:

Buserelin

therapeutische indicaties:

Hormone

Autorisatie-status:

Authorised

Autorisatie datum:

2008-09-05

Productkenmerken

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Busol 0.004 mg/ml solution for injection for cattle, horses, rabbits
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Solution for injection
Clear, colourless liquid
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle, horse, rabbit
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
COW:
Induction of ovulation in cows with a dominant follicle
Synchronisation of oestrus and induction of ovulation
Treatment of ovarian follicular cysts
MARE:
Induction of ovulation in oestrus mares
Improvement of pregnancy rate
RABBIT:
Ovulation induction at post partum insemination
Improvement of conception rate
4.3 CONTRAINDICATIONS
Do not use in animals with known hypersensitivity to the active
ingredient.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Treatment with a GnRH analogue is only symptomatic; the causes
underlying a fertility disorder are not eliminated by
this treatment.
Each ml contains
ACTIVE SUBSTANCE
Buserelin (as Buserelin acetate)
0.004 mg/ml
EXCIPIENT(S)
Benzyl alcohol (E1519)
20.0
mg/ml
For a full list of excipients, see section 6.1.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_1_
_/_
_0_
_3_
_/_
_2_
_0_
_1_
_7_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_5_
_9_
_8_
_1_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Not applicable.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY MEDICINAL P
                                
                                Lees het volledige document
                                
                            

Zoekwaarschuwingen met betrekking tot dit product